Humanigen Inc (HGENQ)

[cowtown jay]

Another miss for Gilead, in a key market segment for ADC's.

"Trodelvy belongs to a class of widely sought-out treatments called antibody-drug conjugates, or ADCs, which deliver a cancer-killing therapy to specifically target and kill cancer cells and minimize damage to healthy ones. Standard chemotherapy is less selective — it can affect both cancer cells and healthy cells.

ADCs are one of the hottest areas of the pharmaceutical industry, as large drugmakers ink deals to acquire or co-develop them."

https://www.cnbc.com/2024/01/22/gilead-stock-falls-after-disappointing-lung-cancer-study-results.html